Asymmetric Bisamidation of Malonic Esters via Direct Amidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for producing asymmetric malonic acid bisanilides, such as cabozantinib, are inefficient due to multiple steps, the use of corrosive acid chlorides, and low yields, with no direct method for converting ester functionalities into amides without saponification and subsequent activation of acids.
Innovation Solution
A two-step process involving the reaction of a 1,1-disubstituted dicarboxylic acid ester with alkali or alkaline earth metal salts of amines to form asymmetric bisamides, allowing for the direct formation of amide bonds without the need for chromatographic purification and minimizing the use of corrosive reagents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multiple steps are used to convert ester to amide via saponification and acid chloride formation, then the conversion can be achieved, but the process complexity and time increase
Solution Approach 1:
The patent combines saponification, activation, and amidation steps into a single direct conversion process. The ester reacts directly with the amine in the presence of a base to form the amide, eliminating the need for separate saponification and acid chloride formation steps. This merging of operations reduces process complexity while maintaining conversion efficiency.
Solution Approach 2:
The patent uses a base (such as alkali metal hydroxide or carbonate) to pre-activate the ester functionality in situ, allowing direct nucleophilic attack by the amine. This preliminary activation eliminates the need for separate activation steps using corrosive reagents like thionyl chloride or oxalyl chloride.
2Ease of manufacture
If acid chlorides are used as intermediates, then amide bond formation can proceed, but corrosive reagents and safety issues arise
Solution Approach 1:
The patent replaces harmful corrosive reagents (acid chlorides, thionyl chloride, oxalyl chloride) with benign alternatives. Instead of forming reactive acid chlorides that require careful handling, the process uses mild bases to directly facilitate amide bond formation from esters and amines, eliminating safety hazards while maintaining manufacturing efficiency.
Solution Approach 2:
The patent introduces a base (such as NaOH, KOH, Na2CO3, or K2CO3) as an intermediary that mediates the reaction between ester and amine. The base activates the ester carbonyl group in situ, enabling direct nucleophilic attack by the amine without forming corrosive acid chloride intermediates. This intermediary approach simplifies the reaction pathway and eliminates harmful substances.
3Productivity
If sequential reaction with metal salts of amines is used, then asymmetric bisamides can be formed directly, but yield optimization is required
Solution Approach 1:
The patent optimizes reaction parameters including the choice of base (alkali metal hydroxide, carbonate, or bicarbonate), solvent (polar aprotic solvents like DMF, DMSO, or acetonitrile), temperature (reflux or elevated temperatures), and stoichiometry of reagents. These parameter adjustments ensure high yields of asymmetric bisamides while maintaining the efficiency of direct conversion from esters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process provides a scalable and efficient method for producing pure asymmetric bisamides in good to excellent yields, avoiding the drawbacks of existing multi-step processes and corrosive intermediates.
Implementation Method 1
both amide bonds are formed by sequential reaction of the ester carbonyl group with the amine
Data Source
Figure 1
AI summary
The present invention relates to processes, process steps and intermediates useful in the asymmetric bisamidation of malonic ester derivatives wherein the new processes, process steps and intermediates are, for example, useful in the preparation of asymmetric malonic acid bisanilides such as cabozantinib.